Analysis of the role of the C-terminal tail in the regulation of the epidermal growth factor receptor

Molecular and Cellular Biology

Volumn 35, Issue 17, 2015, Pages 3083-3102

  Kovacs, Erika ^a,b   Das, Rahul ^a,b   Wang, Qi ^a,b   Collier, Timothy S ^d   Cantor, Aaron ^a,b   Huang, Yongjian ^a,b   Wong, Kathryn ^a,b   Mirza, Amar ^a,f   Barros, Tiago ^a,b   Grob, Patricia ^a   Jura, Natalia ^e   Bose, Ron ^d   Kuriyan, John ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PHOSPHOTRANSFERASE; TYROSINE;

ARTICLE; AUTOPHOSPHORYLATION; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CRYSTAL STRUCTURE; CYTOPLASM; DIMERIZATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; MEMBRANE RECONSTITUTION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; AMINO ACID SEQUENCE; ANIMAL; CELL LINE; CHLOROCEBUS AETHIOPS; COS 1 CELL LINE; ENZYME ACTIVATION; GENE DELETION; GENETICS; HEK293 CELL LINE; METABOLISM; MOLECULAR DYNAMICS; PHOSPHORYLATION; PROTEIN TERTIARY STRUCTURE; ULTRASTRUCTURE; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; COS CELLS; CRYSTALLOGRAPHY, X-RAY; ENZYME ACTIVATION; FLOW CYTOMETRY; HEK293 CELLS; HUMANS; MOLECULAR DYNAMICS SIMULATION; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, EPIDERMAL GROWTH FACTOR; SEQUENCE DELETION;

EID: 84938841076     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00248-15     Document Type: Article

References (50)

1. Arteaga CL, Engelman JA. 2014. ERBB receptors: from oncogene discovery to basic science to mechanism-based cancer therapeutics. Cancer Cell 25:282-303. http://dx.doi.org/10.1016/j.ccr.2014.02.025.
2. Kovacs E, Zorn JA, Huang Y, Barros T, Kuriyan J. 2015. A structural perspective on the regulation of the epidermal growth factor receptor. Annu Rev Biochem 84:739-764. http://dx.doi.org/10.1146/annurev -biochem-060614-034402.
3. Yarden Y, Sliwkowski MX. 2001. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2:127-137. http://dx.doi.org/10.1038/35052073.
4. Endres NF, Barros T, Cantor AJ, Kuriyan J. 2014. Emerging concepts in the regulation of the EGF receptor and other receptor tyrosine kinases. Trends Biochem Sci 39:437-446. http://dx.doi.org/10.1016/j.tibs.2014.08.001.
5. Lemmon MA, Schlessinger J, Ferguson KM. 2014. The EGFR family: not so prototypical receptor tyrosine kinases. Cold Spring Harb Perspect Biol 6:a020768. http://dx.doi.org/10.1101/cshperspect.a020768.
6. Wagner MJ, Stacey MM, Liu BA, Pawson T. 2013. Molecular mechanisms of SH2- and PTB-domain-containing proteins in receptor tyrosine kinase signaling. Cold Spring Harb Perspect Biol 5:a008987. http://dx.doi.org/10.1101/cshperspect.a008987.
7. Shan Y, Eastwood MP, Zhang X, Kim ET, Arkhipov A, Dror RO, Jumper J, Kuriyan J, Shaw DE. 2012. Oncogenic mutations counteract intrinsic disorder in the EGFR kinase and promote receptor dimerization. Cell 149:860-870. http://dx.doi.org/10.1016/j.cell.2012.02.063.
8. Leahy DJ. 2004. Structure and function of the epidermal growth factor (EGF/ErbB) family of receptors. Adv Protein Chem 68:1-27. http://dx.doi.org/10.1016/S0065-3233(04)68001-6.
9. Ferguson KM, Berger MB, Mendrola JM, Cho HS, Leahy DJ, Lemmon MA. 2003. EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization. Mol Cell 11:507-517. http://dx.doi.org/10.1016/S1097-2765(03)00047-9.
10. Garrett TP, McKern NM, Lou M, Elleman TC, Adams TE, Lovrecz GO, Zhu HJ, Walker F, Frenkel MJ, Hoyne PA, Jorissen RN, Nice EC, Burgess AW, Ward CW. 2002. Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha. Cell 110:763-773. http://dx.doi.org/10.1016/S0092-8674(02)00940-6.
11. Ogiso H, Ishitani R, Nureki O, Fukai S, Yamanaka M, Kim JH, Saito K, Sakamoto A, Inoue M, Shirouzu M, Yokoyama S. 2002. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell 110:775-787. http://dx.doi.org/10.1016/S0092-8674(02)00963-7.
12. Zhang X, Gureasko J, Shen K, Cole PA, Kuriyan J. 2006. An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor. Cell 125:1137-1149. http://dx.doi.org/10.1016/j.cell.2006.05.013.
13. Endres NF, Das R, Smith AW, Arkhipov A, Kovacs E, Huang Y, Pelton JG, Shan Y, Shaw DE, Wemmer DE, Groves JT, Kuriyan J. 2013. Conformational coupling across the plasma membrane in activation of the EGF receptor. Cell 152:543-556. http://dx.doi.org/10.1016/j.cell.2012.12.032.
14. Red Brewer M, Choi SH, Alvarado D, Moravcevic K, Pozzi A, Lemmon MA, Carpenter G. 2009. The juxtamembrane region of the EGF receptor functions as an activation domain. Mol Cell 34:641-651. http://dx.doi.org/10.1016/j.molcel.2009.04.034.
15. Jura N, Endres NF, Engel K, Deindl S, Das R, Lamers MH, Wemmer DE, Zhang X, Kuriyan J. 2009. Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment. Cell 137:1293-1307. http://dx.doi.org/10.1016/j.cell.2009.04.025.
16. Arkhipov A, Shan Y, Das R, Endres NF, Eastwood MP, Wemmer DE, Kuriyan J, Shaw DE. 2013. Architecture and membrane interactions of the EGF receptor. Cell 152:557-569. http://dx.doi.org/10.1016/j.cell.2012.12.030.
17. Scheck RA, Lowder MA, Appelbaum JS, Schepartz A. 2012. Bipartite tetracysteine display reveals allosteric control of ligand-specific EGFR activation. ACS Chem Biol 7:1367-1376. http://dx.doi.org/10.1021/cb300216f.
18. Bocharov EV, Mineev KS, Volynsky PE, Ermolyuk YS, Tkach EN, Sobol AG, Chupin VV, Kirpichnikov MP, Efremov RG, Arseniev AS. 2008. Spatial structure of the dimeric transmembrane domain of the growth factor receptor ErbB2 presumably corresponding to the receptor active state. J Biol Chem 283:6950-6956. http://dx.doi.org/10.1074/jbc.M709202200.
19. Chen L, Merzlyakov M, Cohen T, Shai Y, Hristova K. 2009. Energetics of ErbB1 transmembrane domain dimerization in lipid bilayers. Biophys J 96:4622-4630. http://dx.doi.org/10.1016/j.bpj.2009.03.004.
20. Mineev KS, Bocharov EV, Pustovalova YE, Bocharova OV, Chupin VV, Arseniev AS. 2010. Spatial structure of the transmembrane domain heterodimer of ErbB1 and ErbB2 receptor tyrosine kinases. J Mol Biol 400:231-243. http://dx.doi.org/10.1016/j.jmb.2010.05.016.
21. Dankort DL, Wang Z, Blackmore V, Moran MF, Muller WJ. 1997. Distinct tyrosine autophosphorylation sites negatively and positively modulate neu-mediated transformation. Mol Cell Biol 17:5410-5425.
22. Pines G, Huang PH, Zwang Y, White FM, Yarden Y. 2010. EGFRvIV: a previously uncharacterized oncogenic mutant reveals a kinase autoinhibitory mechanism. Oncogene 29:5850-5860. http://dx.doi.org/10.1038/onc.2010.313.
23. Sorkin A, Mazzotti M, Sorkina T, Scotto L, Beguinot L. 1996. Epidermal growth factor receptor interaction with clathrin adaptors is mediated by the Tyr974-containing internalization motif. J Biol Chem 271:13377-13384. http://dx.doi.org/10.1074/jbc.271.23.13377.
24. Bublil EM, Pines G, Patel G, Fruhwirth G, Ng T, Yarden Y. 2010. Kinase-mediated quasi-dimers of EGFR. FASEB J 24:4744-4755. http://dx.doi.org/10.1096/fj.10-166199.
25. Koushik SV, Chen H, Thaler C, Puhl HL, III, Vogel SS. 2006. Cerulean, Venus, and VenusY67C FRET reference standards. Biophys J 91:L99-L101. http://dx.doi.org/10.1529/biophysj.106.096206.
26. Otwinowski Z, Minor W. 1997. Processing of X-ray diffraction data collected in oscillation mode. Macromol Crystallogr Part A 276:307-326. http://dx.doi.org/10.1016/S0076-6879(97)76066-X.
27. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ. 2007. Phaser crystallographic software. J Appl Crystallogr 40:658-674. http://dx.doi.org/10.1107/S0021889807021206.
28. Emsley P, Cowtan K. 2004. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60:2126-2132. http://dx.doi.org/10.1107/S0907444904019158.
29. Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung LW, Kapral GJ, Grosse-Kunstleve RW, McCoy AJ, Moriarty NW, Oeffner R, Read RJ, Richardson DC, Richardson JS, Terwilliger TC, Zwart PH. 2010. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66:213-221. http://dx.doi.org/10.1107/S0907444909052925.
30. Chen VB, Arendall WB, Headd JJ, Keedy DA, Immormino RM, Kapral GJ, Murray LW, Richardson JS, Richardson DC. 2010. Mol-Probity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr 66:12-21. http://dx.doi.org/10.1107/S0907444909042073.
31. Case DA, Cheatham TE, III, Darden T, Gohlke H, Luo R, Merz KM, Jr, Onufriev A, Simmerling C, Wang B, Woods RJ. 2005. The Amber biomolecular simulation programs. J Comput Chem 26:1668-1688. http://dx.doi.org/10.1002/jcc.20290.
32. Lindorff-Larsen K, Piana S, Palmo K, Maragakis P, Klepeis JL, Dror RO, Shaw DE. 2010. Improved side-chain torsion potentials for the Amber ff99SB protein force field. Proteins 78:1950-1958.
33. Zhang X, Pickin KA, Bose R, Jura N, Cole PA, Kuriyan J. 2007. Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface. Nature 450:741-744. http://dx.doi.org/10.1038/nature05998.
34. Brunger AT, Adams PD, Clore GM, DeLano WL, Gros P, Grosse-Kunstleve RW, Jiang JS, Kuszewski J, Nilges M, Pannu NS, Read RJ, Rice LM, Simonson T, Warren GL. 1998. Crystallography&NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr 54:905-921.
35. Ryckaert JP, Ciccotti G, Berendsen HJC. 1977. Numerical integration of Cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J Comput Physics 23:327-341. http://dx.doi.org/10.1016/0021-9991(77)90098-5.
36. Berendsen HJC, Postma JPM, Vangunsteren WF, Dinola A, Haak JR. 1984. Molecular dynamics with coupling to an external bath. J Chem Phys 81:3684-3690. http://dx.doi.org/10.1063/1.448118.
37. Huth JR, Bewley CA, Jackson BM, Hinnebusch AG, Clore GM, Gronenborn AM. 1997. Design of an expression system for detecting folded protein domains and mapping macromolecular interactions by NMR. Protein Sci 6:2359-2364.
38. Schneider CA, Rasband WS, Eliceiri KW. 2012. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9:671-675. http://dx.doi.org/10.1038/nmeth.2089.
39. Shevchenko A, Tomas H, Havlis J, Olsen JV, Mann M. 2006. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc 1:2856-2860.
40. Huang CY, Ferrell JE, Jr. 1996. Ultrasensitivity in the mitogen-activated protein kinase cascade. Proc Natl Acad Sci U S A 93:10078-10083. http://dx.doi.org/10.1073/pnas.93.19.10078.
41. Clayton AH, Orchard SG, Nice EC, Posner RG, Burgess AW. 2008. Predominance of activated EGFR higher-order oligomers on the cell surface. Growth Factors 26:316-324. http://dx.doi.org/10.1080/08977190802442187.
42. Bergamin E, Hallock PT, Burden SJ, Hubbard SR. 2010. The cytoplasmic adaptor protein Dok7 activates the receptor tyrosine kinase MuSK via dimerization. Mol Cell 39:100-109. http://dx.doi.org/10.1016/j.molcel.2010.06.007.
43. Herbst R, Burden SJ. 2000. The juxtamembrane region of MuSK has a critical role in agrin-mediated signaling. EMBO J 19:67-77. http://dx.doi.org/10.1093/emboj/19.1.67.
44. Tice DA, Biscardi JS, Nickles AL, Parsons SJ. 1999. Mechanism of biological synergy between cellular Src and epidermal growth factor receptor. Proc Natl Acad Sci U S A 96:1415-1420. http://dx.doi.org/10.1073/pnas.96.4.1415.
45. Zhang Q, Park E, Kani K, Landgraf R. 2012. Functional isolation of activated and unilaterally phosphorylated heterodimers of ERBB2 and ERBB3 as scaffolds in ligand-dependent signaling. Proc Natl Acad Sci U S A 109:13237-13242. http://dx.doi.org/10.1073/pnas.1200105109.
46. Macdonald-Obermann JL, Piwnica-Worms D, Pike LJ. 2012. Mechanics of EGF receptor/ErbB2 kinase activation revealed by luciferase fragment complementation imaging. Proc Natl Acad Sci U S A 109:137-142. http://dx.doi.org/10.1073/pnas.1111316109.
47. Ward MD, Leahy DJ. 2015. Kinase activator-receiver preference in ErbB heterodimers is determined by intracellular regions and is not coupled to extracellular asymmetry. J Biol Chem 290:1570-1579. http://dx.doi.org/10.1074/jbc.M114.612085.
48. Mi LZ, Lu C, Li Z, Nishida N, Walz T, Springer TA. 2011. Simultaneous visualization of the extracellular and cytoplasmic domains of the epidermal growth factor receptor. Nat Struct Mol Biol 18:984-989. http://dx.doi.org/10.1038/nsmb.2092.
49. Wang Z, Longo PA, Tarrant MK, Kim K, Head S, Leahy DJ, Cole PA. 2011. Mechanistic insights into the activation of oncogenic forms of EGF receptor. Nat Struct Mol Biol 18:1388-1393. http://dx.doi.org/10.1038/nsmb.2168.
50. Kim Y, Li Z, Apetri M, Luo B, Settleman JE, Anderson KS. 2012. Temporal resolution of autophosphorylation for normal and oncogenic forms of EGFR and differential effects of gefitinib. Biochemistry 51:5212-5222. http://dx.doi.org/10.1021/bi300476v.